Ibrahim Ramy Riad Ahmed Insider Profile
4 Followers
Ibrahim Ramy Riad Ahmed, President, PDT BU at Takeda Pharmaceutical Company, holds 102.59K shares in Takeda Pharmaceutical Company (Ticker: TAK). Most recently, Ibrahim Ramy Riad Ahmed Sold 7,277 shares of Takeda Pharmaceutical Company on Aug 12, 2026 for an estimated value of $124.44K.
Ibrahim Ramy Riad Ahmed has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Ibrahim Ramy Riad Ahmed's holdings
Insider Roles
President, PDT BU
Roles that Ibrahim Ramy Riad Ahmed holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Ibrahim Ramy Riad Ahmed
Ibrahim Ramy Riad Ahmed's Trading History
List of latest transactions for each holding click on a transaction to see Ibrahim Ramy Riad Ahmed's performance on stock
You May Also Like
Ibrahim Ramy Riad Ahmed insider profile FAQ
What is the percentage of profitable transactions made by Ibrahim Ramy Riad Ahmed?
The percentage of profitable transactions made by Ibrahim Ramy Riad Ahmed is ―.
What is the average return per transaction made by Ibrahim Ramy Riad Ahmed?
The average return per transaction made by Ibrahim Ramy Riad Ahmed is ―.
What stocks does Ibrahim Ramy Riad Ahmed hold?
Ibrahim Ramy Riad Ahmed holds: TAK stocks.
What was Ibrahim Ramy Riad Ahmed’s latest transaction?
Ibrahim Ramy Riad Ahmed latest transaction was an Informative Sell of $124.44K.
What was Ibrahim Ramy Riad Ahmed's most profitable transaction?
Ibrahim Ramy Riad Ahmed’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Ibrahim Ramy Riad Ahmed's role in Takeda Pharmaceutical Company?
Ibrahim Ramy Riad Ahmed's role in Takeda Pharmaceutical Company is President, PDT BU.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.